A detailed history of Carr Financial Group Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Carr Financial Group Corp holds 8,133 shares of MRK stock, worth $1.02 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
8,133
Previous 8,024 1.36%
Holding current value
$1.02 Million
Previous $1.06 Billion 4.9%
% of portfolio
0.32%
Previous 0.35%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$123.8 - $132.96 $13,494 - $14,492
109 Added 1.36%
8,133 $1.01 Billion
Q3 2023

Nov 06, 2023

SELL
$102.95 - $114.33 $34,488 - $38,300
-335 Reduced 4.01%
8,024 $830 Million
Q2 2023

Jul 14, 2023

SELL
$108.61 - $118.38 $9,774 - $10,654
-90 Reduced 1.07%
8,359 $971 Million
Q1 2023

Apr 19, 2023

BUY
$102.94 - $114.86 $30,573 - $34,113
297 Added 3.64%
8,449 $905 Million
Q4 2022

Feb 13, 2023

BUY
$87.44 - $112.11 $712,810 - $913,920
8,152 New
8,152 $910 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $319B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Carr Financial Group Corp Portfolio

Follow Carr Financial Group Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carr Financial Group Corp, based on Form 13F filings with the SEC.

News

Stay updated on Carr Financial Group Corp with notifications on news.